You are here: vision-research.eu » News » Newsdetails: Congress and FDA nominee heap love on ‘adaptive...

General

Congress and FDA nominee heap love on ‘adaptive trials’

April 21, 2017

This week, as President Donald Trump’s nominee to head FDA, Gottlieb sat before Republican lawmakers hungry for promises of “shorter time frames” for drug and device approvals, and again expressed his zeal - repeatedly - for adaptive trial designs.

If confirmed to be FDA’s head, as expected, Gottlieb suggested he’d promote wider use of the approach.


Missing some information on vision-research.eu?

* mandatory field